- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 39-53 of
362 results
2065 Exhibit: Ex 2065 Gao 2023
Document
IPR2025-01346, No. 2065 Exhibit - Ex 2065 Gao 2023 (P.T.A.B. Nov. 12, 2025)
|
|
Cite Document
2064 Exhibit: Ex 2064 USP Appl Publ 2016 0015788 A1 Holscher
Document
IPR2025-01346, No. 2064 Exhibit - Ex 2064 USP Appl Publ 2016 0015788 A1 Holscher (P.T.A.B. Nov. 12, 2025)
|
|
Cite Document
2096 Exhibit: Ex 2096 Eli Lilly Co, Q3 2025 Earnings Call Presentation
Document
IPR2025-01346, No. 2096 Exhibit - Ex 2096 Eli Lilly Co, Q3 2025 Earnings Call Presentation (P.T.A.B. Nov. 12, 2025)
|
|
Cite Document
2078 Exhibit: Ex 2078 Zepbound FDA Approval
Document
IPR2025-01346, No. 2078 Exhibit - Ex 2078 Zepbound FDA Approval (P.T.A.B. Nov. 12, 2025)
|
|
Cite Document
2061 Exhibit: Ex 2061 Timofte 2013
Document
IPR2025-01346, No. 2061 Exhibit - Ex 2061 Timofte 2013 (P.T.A.B. Nov. 12, 2025)
|
|
Cite Document
2092 Exhibit: Ex 2092 Eli Lilly Press Release 5242024
Document
IPR2025-01346, No. 2092 Exhibit - Ex 2092 Eli Lilly Press Release 5242024 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2026 Exhibit: Ex 2026 Zoler Medscape June 2022
Document
IPR2025-01346, No. 2026 Exhibit - Ex 2026 Zoler Medscape June 2022 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2050 Exhibit: Ex 2050 Eli Lilly Tirzepatide Non NCT Clinical Trials compilation
Document
IPR2025-01346, No. 2050 Exhibit - Ex 2050 Eli Lilly Tirzepatide Non NCT Clinical Trials compilation (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2018 Exhibit: Ex 2018 Eli Lilly Press Release 2172021
Document
IPR2025-01346, No. 2018 Exhibit - Ex 2018 Eli Lilly Press Release 2172021 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2041 Exhibit: Ex 2041 Zacks Equity Rsch Nasdaq 12102020
Document
IPR2025-01346, No. 2041 Exhibit - Ex 2041 Zacks Equity Rsch Nasdaq 12102020 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2010 Exhibit: Ex 2010 Coskun et al Molecular Metabolism 2018
Document
IPR2025-01346, No. 2010 Exhibit - Ex 2010 Coskun et al Molecular Metabolism 2018 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2024 Exhibit: Ex 2024 Wadden et al Nature Med 2023
Document
IPR2025-01346, No. 2024 Exhibit - Ex 2024 Wadden et al Nature Med 2023 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2031 Exhibit: Ex 2031 Drug Discovery Development 632021
Document
IPR2025-01346, No. 2031 Exhibit - Ex 2031 Drug Discovery Development 632021 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2006 Exhibit: Ex 2006 Fierce Healthcare 9232011
Document
IPR2025-01346, No. 2006 Exhibit - Ex 2006 Fierce Healthcare 9232011 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
2017 Exhibit: Ex 2017 Eli Lilly Press Release 1292020
Document
IPR2025-01346, No. 2017 Exhibit - Ex 2017 Eli Lilly Press Release 1292020 (P.T.A.B. Oct. 14, 2025)
|
|
Cite Document
